Medicare Enrolled
Dr. Stephen Matter, M.D.
Gastroenterology · Normal, IL
Practice pattern: Mixed Practice
— Diverse clinical practice across multiple procedure types
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Matter from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Matter?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Matter
Dr. Stephen Matter is a gastroenterology specialist in Normal, IL, with 19 years of NPI registration. Based on federal Medicare data, Dr. Matter performed 14,321 Medicare services across 2,362 unique beneficiaries.
Between the years covered by Open Payments, Dr. Matter received a total of $13,930 from 45 pharmaceutical and/or device companies across 937 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in gastroenterology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Matter is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 19 years in practice
▲ Top 1% volume in IL
$13,930 industry payments
Medicare Practice Summary
Medicare Utilization ↗14,321
Medicare services
Top 1% in IL for gastroenterology
2,362
Unique beneficiaries
$15
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~754 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Contrast dye for imaging (iodine-based) A contrast agent containing 300-399 mg/ml of iodine used to enhance imaging studies. It is administered per milliliter to improve the visibility of internal structures. |
11,700 | $0 | $4 |
| Upper GI endoscopy with biopsy A procedure to collect tissue samples from the esophagus, stomach, or upper small intestine using a flexible tube with a camera. The samples are examined to check for abnormalities. |
478 | $15 | $1,553 |
| Upper endoscopy with biopsy A procedure using a flexible tube to examine the esophagus, stomach, and upper small intestine, during which tissue samples are collected for microscopic analysis. |
429 | $95 | $622 |
| Esophageal dilation with guide wire and endoscope A flexible endoscope is used to insert a guide wire into the esophagus, followed by dilation to widen the esophageal passage. |
302 | $40 | $1,763 |
| Office visit, established patient (10-19 min) An office visit for an existing patient lasting 10 to 19 minutes. The visit involves medical evaluation and management of the patient's condition. |
250 | $39 | $187 |
| Colon polyp removal with endoscope and cautery This procedure removes polyps or growths from the large bowel using a flexible tube with a camera. Electrical cautery is used to stop bleeding during the removal. |
171 | $174 | $3,092 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
153 | $86 | $469 |
| Endoscopic removal of esophagus, stomach, or small bowel polyps This procedure uses a flexible endoscope to remove polyps or growths from the esophagus, stomach, or upper small intestine. Electrical cautery is applied during the removal process. |
146 | $132 | $2,026 |
| Colonoscopy with biopsy A procedure to collect tissue samples from the large intestine using a flexible tube with a camera. The samples are examined to check for abnormalities or disease. |
133 | $92 | $2,546 |
| External hemorrhoid removal by rubber banding A procedure to remove external hemorrhoids using rubber bands to cut off blood supply. The affected tissue is tied off and eventually falls off. |
122 | $127 | $1,824 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
102 | $65 | $315 |
| CT scan of abdomen and pelvis with contrast A CT scan of the abdomen and pelvis using contrast dye before and after administration to visualize internal structures. |
71 | $259 | $3,694 |
| Complete ultrasound of abdomen A diagnostic imaging test that uses sound waves to create detailed pictures of the organs and structures within the abdomen. |
63 | $79 | $646 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
63 | $110 | $559 |
| CT scan of abdomen and pelvis, without contrast A computed tomography scan that creates detailed images of the abdominal and pelvic organs. The procedure is performed without the use of intravenous contrast dye. |
53 | $141 | $2,677 |
| CT scan of abdomen and pelvis with contrast A CT scan that uses dye to create detailed images of the abdomen and pelvis. This imaging test helps doctors examine internal organs and structures in these areas. |
35 | $225 | $3,081 |
| Office visit for established patient An office visit for an existing patient that may not require the healthcare professional to be present. |
29 | $15 | $96 |
| Colonoscopy for colorectal cancer screening, high risk A colonoscopy performed to screen for colorectal cancer in individuals identified as being at high risk for the disease. |
21 | $166 | $2,084 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
Industry Payment Transparency
Open Payments through 2024 ↗$13,930
Total received (2018-2024)
Avg $1,990/year across 7 years
Top 15% in IL for gastroenterology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
45
Companies
937
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$13,790 (99.0%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$140 (1.0%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$2,756
2023
$2,231
2022
$2,202
2021
$1,919
2020
$1,355
2019
$1,807
2018
$1,660
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
ABBVIE INC.
$799
Janssen Biotech, Inc.
$369
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$336
Takeda Pharmaceuticals U.S.A., Inc.
$296
AIMMUNE THERAPEUTICS, INC.
$190
Braintree Laboratories, Inc.
$136
Phathom Pharmaceuticals, Inc.
$129
Organon Llc
$81
Madrigal Pharmaceuticals
$67
PFIZER INC.
$60
Ardelyx, Inc.
$50
QOL Medical, LLC
$41
Daiichi Sankyo Inc.
$40
Celgene Corporation
$33
Mauna Kea Technologies, Inc.
$28
IRONWOOD PHARMACEUTICALS, INC
$27
Boehringer Ingelheim Pharmaceuticals, Inc.
$18
Sandoz Inc.
$15
Merck Sharp & Dohme LLC
$14
Celltrion USA Inc.
$13
Ferring Pharmaceuticals Inc.
$13
Top 3 companies account for 54.6% of 2024 payments
All-time payments by company (2018-2024) ›
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$2,193
ABBVIE INC.
$2,043
Takeda Pharmaceuticals U.S.A., Inc.
$1,392
Janssen Biotech, Inc.
$1,289
AbbVie Inc.
$1,015
AbbVie, Inc.
$851
Celgene Corporation
$529
Ironwood Pharmaceuticals, Inc
$377
Braintree Laboratories, Inc.
$338
UCB, Inc.
$319
Ferring Pharmaceuticals Inc.
$300
Mauna Kea Technologies, Inc.
$291
Gilead Sciences, Inc.
$279
PFIZER INC.
$265
Merck Sharp & Dohme Corporation
$248
Daiichi Sankyo Inc.
$200
AIMMUNE THERAPEUTICS, INC.
$190
Nestle HealthCare Nutrition Inc.
$179
Janssen Pharmaceuticals, Inc
$167
Phathom Pharmaceuticals, Inc.
$151
Concordia Pharmaceuticals Inc.
$148
QOL Medical, LLC
$100
Intercept Pharmaceuticals, Inc.
$97
Ardelyx, Inc.
$87
Organon Llc
$81
Amgen Inc.
$78
Merck Sharp & Dohme LLC
$77
RedHill Biopharma Inc.
$70
Madrigal Pharmaceuticals
$67
NESTLE HEALTHCARE NUTRITION INC.
$61
Shionogi Inc
$48
Celltrion USA Inc.
$46
Prometheus Laboratories Inc.
$38
Fresenius Kabi USA, LLC
$35
VIVUS LLC
$34
Novo Nordisk Inc
$32
Alfasigma USA, Inc.
$32
Boehringer Ingelheim Pharmaceuticals, Inc.
$31
Sandoz Inc.
$28
Allergan Inc.
$27
Organon LLC
$27
IRONWOOD PHARMACEUTICALS, INC
$27
CSL Behring
$20
Ethicon US, LLC
$12
Digestive Care, Inc.
$10
Top 3 companies account for 40.4% of all-time payments
Associated products mentioned in payments ›
AMJEVITA · APRISO · AVSOLA · Aemcolo · Amitiza · CIMZIA · CLENPIQ · CREON · CYLTEZO · Cimzia · Creon · DIFICID · DONNATAL · Dexilant · Donnatal · ENTYVIO · EOHILIA · Entyvio · Epclusa · GATTEX · HADLIMA · HUMIRA · HYRIMOZ · Humira · IBSRELA · IDACIO · INFLECTRA · INJECTAFER · Kcentra · LINX Reflux Management System · LINZESS · Linzess · MAVYRET · MOTEGRITY · MOTOFEN · Mavyret · Movantik · Mulpleta · OCALIVA · PANCREAZE · Pancreaze · Pertzye · REBYOTA · REMICADE · RENFLEXIS · RESMETIROM · RINVOQ · SKYRIZI · STELARA · SUCRAID · SUFLAVE · SUPREP · SUPREP BOWEL PREP · SUTAB · Sucraid · TREMFYA · TRULANCE · UCERIS · VELSIPITY · VIBERZI · VOQUEZNA · VOWST · XELJANZ · XIFAXAN · YUFLYMA · ZENPEP · ZEPATIER · ZEPOSIA · ZYMFENTRA
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (99%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Geographic Context
Gastroenterologists within 10 mi
8
Per 100K population
4.7
County median income
$78,329
Nearest hospital
CARLE BROMENN MEDICAL CENTER
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Matter is a mixed practice specialist, with above-average Medicare volume (top 1% in IL), with low-engagement industry engagement in the top 15% of IL peers, with 19 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Matter experienced with contrast dye for imaging (iodine-based)?
Based on Medicare claims data, Dr. Matter performed 11,700 contrast dye for imaging (iodine-based) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Matter receive payments from pharmaceutical companies?
Yes. Dr. Matter received a total of $13,930 from 45 companies across 937 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Matter's costs compare to other gastroenterologists in Normal?
Dr. Matter's average Medicare payment per service is $15. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Matter) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Specialty guide
Understanding Gastroenterology
Common procedures, typical costs, and what industry payments mean in gastroenterology.
Same specialty & city
Gastroenterologists in Normal
Browse gastroenterologists in Normal ranked by procedure volume and transparency data.
Highest volume
Top Gastroenterologists in IL
Gastroenterologists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Gastroenterologists in IL
Which IL gastroenterologists receive the most from drug and device companies.
By company
Salix Pharmaceuticals, a division of Bausch Health US, LLC Payments to Doctors
See all physicians who received payments from Salix Pharmaceuticals, a division of Bausch Health US, LLC.
By company
ABBVIE INC. Payments to Doctors
See all physicians who received payments from ABBVIE INC.
By company
Takeda Pharmaceuticals U.S.A., Inc. Payments to Doctors
See all physicians who received payments from Takeda Pharmaceuticals U.S.A., Inc.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology